Australia’s Therapeutic Goods Administration (TGA) is taking a phased approach to regulatory compliance, prioritizing higher-risk medical devices first and gradually expanding requirements to lower-risk categories in the coming years. This structured rollout is designed to manage the complexity of implementation while ensuring that patients and healthcare systems benefit from stronger safeguards at the earliest possible stage.
Why the Phased Rollout Matters
The TGA’s decision to start with high-risk medical devices reflects their critical role in patient care and the potential for harm if safety and performance are not adequately documented. By focusing initially on Class III and Class IIb devices, regulators are setting a high bar for clinical evidence, traceability, and quality management.
For sponsors, this means:
- Earlier deadlines for compliance compared to lower-risk device categories
- More scrutiny on documentation, safety data, and conformity assessment
- Strategic planning required now to avoid bottlenecks closer to the regulatory deadline
Medical Device UDI compliance start dates
The UDI Compliance start dates for each device class are outlined in the table below
| Requirement | Class III | Class IIb | Class IIa | Class Is* |
|---|---|---|---|---|
| Placing UDI Carrier on the label of device(s) | 1 July 2026 | 1 July 2026 | 1 July 2027 | 1 July 2028 |
| Submitting UDI-DIs and related data to the AusUDID | 1 July 2026 | 1 July 2026 | 1 July 2027 | 1 July 2028 |
| Direct Marking of the medical device and supplying Direct Marking DI to the AusUDID | 1 Jan 2028 | 1 Jan 2029 * Not applicable for implantable medical devices. |
*Class Is MD must have UDI, other Class I MDs are voluntary.
In vitro diagnostic (IVD) UDI compliance start dates
The UDI Compliance start dates for IVD device class outlined in the table below
| Requirement | Class 4 IVD | Class 3 IVD | Class 2 IVD | Class 1* IVD |
|---|---|---|---|---|
| Placing UDI Carrier on the label of IVD(s) | 1 July 2028 | 1 July 2028 | 1 July 2029 | 1 July 2029 |
| Submitting UDIs and related data to the AusUDID | 1 July 2028 | 1 July 2028 | 1 July 2029 | 1 July 2029 |
| Direct Marking of the IVD and supplying Direct Marking DI to the AusUDID | 1 July 2029 | 1 July 2029 | 1 July 2030 | 1 July 2030 |
Key Compliance Deadline: July 2026
Sponsors of Class III and Class IIb medical devices are expected to meet the TGA’s new requirements by July 2026. While that may seem like a long runway, preparation is time-consuming. Gathering technical documentation, validating data, and aligning with conformity assessments requires coordination across regulatory, quality, and manufacturing teams.
What sponsors should prioritize now:
- Gap analysis: Review existing technical files against TGA expectations
- Clinical evidence updates: Ensure supporting data meets the latest standards
- System readiness: Update labeling, UDI (Unique Device Identification), and data exchange processes
- Regulatory submissions: Allow time for reviews and potential back-and-forth with regulators
The Bigger Picture: Lower-Risk Devices Come Later
While current focus is on higher-risk categories, the TGA has scheduled UDI requirements for lower-risk medical devices Class IIa and Class Is, and IVD devices. Sponsors in those categories should take note—watching how the process unfolds now can inform smarter planning for their own compliance journey.
How Sponsors Can Get Ahead
With July 2026 on the horizon, the organizations that begin planning and acting early will be best positioned to meet the requirements smoothly. Establishing a proactive roadmap now will help avoid last-minute scrambling, reduce compliance risks, and strengthen market access in Australia.
Bottom line: If you’re a sponsor of Class III or Class IIb devices, the clock is already ticking. Now is the time to assess your readiness, close documentation gaps, and prepare for the TGA’s July 2026 compliance deadline.
We can help you navigate every step of the process — from gap analysis to submission support. Let’s talk about how we can streamline your compliance journey and ensure you’re ready on time.